We are live on
!
Find out more
O
OrbiMed Portfolio holdings
AUM
$4.59B
1-Year Est. Return
125.28%
This Fund
S&P 500
This Quarter
Est. Return
+7.88%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$3.98B
AUM Growth
-$187M
(-4.5%)
Cap. Flow
-$236M
Cap. Flow
% of AUM
-5.94%
Top 10 Holdings %
Top 10 Hldgs %
49.18%
Holding
122
New
13
Increased
19
Reduced
24
Closed
22
Top Buys
| 1 |
CAI
Caris Life Sciences
CAI
|
+$81.8M |
| 2 |
UnitedHealth
UNH
|
+$51.6M |
| 3 |
Roivant Sciences
ROIV
|
+$30.1M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$23.2M |
| 5 |
JBIO
Jade Biosciences
JBIO
|
+$18.1M |
Top Sells
| 1 |
Pfizer
PFE
|
+$97.6M |
| 2 |
Ionis Pharmaceuticals
IONS
|
+$76.6M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$56.9M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$41.9M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$34.5M |
Sector Composition
| 1 | Healthcare | 99.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMA
76
ImageneBio Inc
IMA
$67.8M
| $4.74M | 0.12% |
294,947
| – | – |
|
|
RPTX
77
DELISTED
Repare Therapeutics
RPTX
| $4.62M | 0.12% |
3,322,488
| – | – |
|
78
Immatics
IMTX
$1.3B
| $3.87M | 0.1% |
719,901
-2,367,561
| -77% | -$11.7M |
|
|
BIOA
79
BioAge Labs
BIOA
$1.02B
| $3.81M | 0.1% |
921,959
| – | – |
|
80
Q32 Bio
QTTB
$292M
| $3.36M | 0.08% |
2,252,987
| – | – |
|
81
enGene Therapeutics
ENGN
$126M
| $2.47M | 0.06% |
677,977
-213,639
| -24% | -$802K |
|
82
Passage Bio
PASG
$14.8M
| $2.42M | 0.06% |
302,765
-48,966
| -14% | -$358K |
|
83
Amylyx Pharmaceuticals
AMLX
$1.94B
| $2.01M | 0.05% |
313,200
-34,800
| -10% | -$169K |
|
|
MURA
84
DELISTED
Mural Oncology
MURA
| $1.45M | 0.04% |
+588,800
| New | +$1.39M |
|
85
Insmed
INSM
$23.7B
| $1.35M | 0.03% |
13,459
-15,200
| -53% | -$1.16M |
|
86
Krystal Biotech
KRYS
$10.2B
| $1.26M | 0.03% |
9,200
-14,300
| -61% | -$2.1M |
|
|
TSBX
87
DELISTED
Turnstone Biologics
TSBX
| $1.11M | 0.03% |
3,099,265
| – | – |
|
|
CMMB
88
Chemomab Therapeutics
CMMB
$11.5M
| $1.09M | 0.03% |
235,248
-200,070
| -46% | -$990K |
|
89
Traws Pharma
TRAW
$10.6M
| $896K | 0.02% |
605,531
| – | – |
|
|
KZR
90
DELISTED
Kezar Life Sciences
KZR
| $883K | 0.02% |
192,700
| – | – |
|
91
Alto Neuroscience
ANRO
$949M
| $550K | 0.01% |
250,000
| – | – |
|
|
DHAI
92
DELISTED
DIH Holdings US
DHAI
| $469K | 0.01% |
76,600
| – | – |
|
93
Lyell Immunopharma
LYEL
$353M
| $457K | 0.01% |
+51,727
| New | +$471K |
|
94
Korro Bio
KRRO
$188M
| $405K | 0.01% |
32,400
| – | – |
|
95
Xeris Biopharma Holdings
XERS
$1.47B
| $376K | 0.01% |
80,420
| – | – |
|
|
LSB
96
DELISTED
LakeShore Biopharma
LSB
| $55.9K | ﹤0.01% |
54,799
-85,629
| -61% | -$108K |
|
97
Amgen
AMGN
$194B
| – | – |
-44,200
| Closed | -$13.8M |
|
98
AstraZeneca
AZN
$263B
| – | – |
0
| – | – |
|
99
Cardiff Oncology
CRDF
$58.6M
| – | – |
-573,884
| Closed | -$1.8M |
|
100
Fate Therapeutics
FATE
$345M
| – | – |
-1,680,580
| Closed | -$1.33M |
|
Similar funds
CGI
LNWTC
SCM
AG
SCM
SV
ANTB
ECM